[Anticoagulation with low molecular weight heparins within the framework of cardioversion for atrial fibrillation].
Tebbe
U
U
Klinikum Lippe GmbH, Fachbereich Herz-Kreislauf, Detmold. ulrich.tebbe@klinikum-lippe.de
D000284:Administration, Oral; D000925:Anticoagulants / Q000008:administration & dosage / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000188:drug therapy / Q000628:therapy*; D017548:Echocardiography, Transesophageal; D004554:Electric Countershock / Q000009:adverse effects; D017984:Enoxaparin / Q000008:administration & dosage / Q000627:therapeutic use*; D006495:Heparin, Low-Molecular-Weight / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D012307:Risk Factors; D013923:Thromboembolism / Q000209:etiology / Q000517:prevention & control*
D000925:Anticoagulants; D017984:Enoxaparin; D006495:Heparin, Low-Molecular-Weight; C403769:certoparin